Biotech Startup OptiKira Receives Federal Grants for Work on Cell Death Prevention

OptiKira, a BioMotiv company, received grants from the National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases totaling nearly $400,000 to support the development of therapeutics that prevent cell death.

Read More  >